While Gerald indicated he is considering a sale of the Diagnostic Division now, I doubt it will happen. If they let all the diagnostics start earning revenue, in a year and a half from now it could be worth 2 billion or more.
Don't forget Dr. Stern and Lympro for Concussion. I think he'll drop a bomb at the Conference in 2 weeks and say we're going to do a validation test and start commercializing it in the second half of 2015.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links